data_2k2s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k2s _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.617 ' HE2' ' HB ' ' A' ' 122' ' ' THR . 80.9 tttt . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.693 0.282 . . . . 1.5900000000000001 110.566 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 m -92.72 95.61 9.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.213 -0.449 . . . . 1.24 110.115 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.758 ' HA ' HG21 ' A' ' 122' ' ' THR . 28.9 mt-10 -87.77 113.27 23.28 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.532 0.682 . . . . 1.1399999999999999 110.595 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.721 HG23 ' HB ' ' A' ' 9' ' ' THR . 3.6 mm -81.37 -61.28 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.892 -1.049 . . . . 1.27 110.46 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.524 ' CE1' ' HB3' ' A' ' 3' ' ' GLU . 39.9 m80 54.79 57.61 5.54 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.894 -0.594 . . . . 3.8700000000000001 110.577 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' O ' HG22 ' A' ' 117' ' ' VAL . . . -153.97 -156.61 7.73 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.361 -0.923 . . . . 1.6100000000000001 111.333 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.53 ' C ' HG23 ' A' ' 117' ' ' VAL . 7.6 m-20 -104.2 -17.79 14.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.185 0.492 . . . . 2.3599999999999999 111.577 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.534 ' HB2' ' HG2' ' A' ' 115' ' ' GLN . 20.0 p -160.74 157.52 27.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.163 0.506 . . . . 1.55 111.174 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.721 ' HB ' HG23 ' A' ' 4' ' ' ILE . 11.8 t -153.05 165.33 35.93 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.069 -0.969 . . . . 1.3700000000000001 109.394 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.44 ' HG2' ' HA ' ' A' ' 113' ' ' SER . 52.6 mtpt -139.84 134.56 31.89 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.356 0.598 . . . . 1.6399999999999999 110.877 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HB2' HD23 ' A' ' 123' ' ' LEU . . . -122.66 167.17 13.77 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.04 -0.982 . . . . 1.21 110.07 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.6 m -108.13 112.38 24.88 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.679 -0.691 . . . . 1.1599999999999999 109.245 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.678 ' O ' ' HA ' ' A' ' 109' ' ' SER . 54.8 tp -84.28 154.6 22.86 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.169 -1.049 . . . . 1.8600000000000001 108.169 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.696 ' HG3' ' HB3' ' A' ' 109' ' ' SER . 34.7 tt0 -150.13 141.37 23.17 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.359 0.6 . . . . 0.85999999999999999 109.539 174.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 4.2 tm-20 -58.31 111.42 1.21 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.487 -1.233 . . . . 1.28 108.863 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.525 ' C ' ' HB2' ' A' ' 128' ' ' LEU . . . 107.64 -4.69 34.69 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 119.745 -1.217 . . . . 0.34000000000000002 111.904 -171.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.699 ' HA ' ' HA ' ' A' ' 127' ' ' THR . 37.3 mt-30 -128.96 160.68 31.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.472 . . . . 1.8 110.728 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.485 ' CG ' ' HA ' ' A' ' 128' ' ' LEU . 1.7 mt-30 -123.59 161.66 24.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.425 -0.807 . . . . 1.76 109.128 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 72' ' ' THR . 11.4 mt -128.82 114.46 16.57 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.822 -0.436 . . . . 1.95 109.822 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.8 m -101.99 133.23 47.14 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.171 0.51 . . . . 1.23 111.215 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 56.1 tp -122.57 115.09 21.56 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.798 -0.637 . . . . 1.96 111.125 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.445 HG22 HG23 ' A' ' 70' ' ' VAL . 2.6 m -93.98 99.7 11.98 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.023 -0.732 . . . . 1.04 109.023 170.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.661 ' CZ ' HD22 ' A' ' 28' ' ' LEU . 8.9 p90 -124.02 169.04 12.04 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.399 -0.593 . . . . 2.73 109.399 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.509 HG12 ' HA ' ' A' ' 68' ' ' PRO . 37.5 mt -124.68 102.14 10.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.355 -0.609 . . . . 1.05 109.355 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.423 ' HB3' ' HE2' ' A' ' 23' ' ' PHE . 16.9 t -134.88 170.56 15.68 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.517 -0.765 . . . . 1.6899999999999999 110.296 -175.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.682 ' HB ' ' HG ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -127.0 -3.58 6.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.299 -0.864 . . . . 1.28 110.69 174.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.611 ' HE2' ' HB2' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -170.96 71.32 0.05 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.661 -0.7 . . . . 1.8799999999999999 109.261 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.661 HD22 ' CZ ' ' A' ' 23' ' ' PHE . 0.5 OUTLIER -89.62 133.88 34.41 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.842 -0.617 . . . . 2.0899999999999999 110.97 -176.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -121.79 126.11 48.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.118 0.485 . . . . 2.0499999999999998 110.111 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 114' ' ' PHE . 1.0 OUTLIER -130.83 155.05 41.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.209 -0.596 . . . . 1.1799999999999999 110.89 -177.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.54 142.72 33.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.901 -1.045 . . . . 0.98999999999999999 109.835 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 36' ' ' HIS . 62.9 t -106.7 133.75 50.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.328 -0.851 . . . . 1.4299999999999999 110.566 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.93 65.55 0.88 Allowed Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.717 -0.674 . . . . 1.0900000000000001 114.507 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -173.87 -71.53 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.687 -1.597 . . . . 3.1200000000000001 106.687 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.5 OUTLIER -161.35 106.39 1.33 Allowed 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.727 -0.669 . . . . 2.2999999999999998 110.679 162.785 22.993 51.153 -158.064 105.727 2.041 105.739 -35.397 -50.026 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.749 ' HE1' HG21 ' A' ' 83' ' ' VAL . 15.2 t-160 -175.03 136.67 0.39 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.681 -0.859 . . . . 2.9399999999999999 108.681 168.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.11 145.24 23.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 118.732 0.696 . . . . 1.76 109.951 171.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.781 HD13 ' HH ' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -151.97 161.2 43.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.113 0.483 . . . . 2.0800000000000001 111.231 -179.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.8 112.69 18.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.085 -0.961 . . . . 1.1399999999999999 109.039 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -82.17 87.84 6.5 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.88 -0.785 . . . . 1.1000000000000001 108.88 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.565 ' HA ' ' CD ' ' A' ' 27' ' ' LYS . 9.8 m120 -78.93 65.94 4.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.482 -0.781 . . . . 2.2200000000000002 109.941 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.677 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 23.1 m-85 -56.26 -45.56 80.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.091 -0.958 . . . . 2.1800000000000002 111.561 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.682 ' HG ' ' HB ' ' A' ' 26' ' ' THR . 60.7 mt -57.09 -53.61 56.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 2.0499999999999998 112.196 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.77 -19.87 64.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.898 0.856 . . . . 1.79 109.577 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.67 44.06 7.01 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.479 -1.237 . . . . 0.58999999999999997 112.438 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.768 ' HB2' HG13 ' A' ' 59' ' ' VAL . 13.8 p90 -152.17 148.24 27.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.041 0.448 . . . . 2.2200000000000002 110.561 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 2.0 tp -114.11 113.77 25.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.036 -0.529 . . . . 1.1299999999999999 110.571 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 13.5 tttt -104.96 134.76 47.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.455 -0.339 . . . . 1.8200000000000001 110.776 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.517 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 37.6 p90 -146.63 141.27 26.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.854 -0.339 . . . . 2.1600000000000001 111.892 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.606 ' HG2' ' CE2' ' A' ' 57' ' ' PHE . 0.8 OUTLIER -121.87 162.15 21.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.037 0.446 . . . . 1.8899999999999999 110.554 176.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.791 HG21 HG13 ' A' ' 101' ' ' VAL . 3.0 p -131.48 102.28 5.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.919 -0.582 . . . . 1.29 110.839 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.29 -172.42 22.72 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.714 -0.955 . . . . 1.8 110.714 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -74.24 -75.46 0.16 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.241 0.52 . . . . 4.1500000000000004 110.056 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -104.98 109.07 20.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.844 -0.798 . . . . 5.1699999999999999 108.844 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.563 ' HB2' HE21 ' A' ' 50' ' ' GLN . 15.0 m -151.98 158.76 43.54 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.211 -0.449 . . . . 2.5299999999999998 110.373 -176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.64 139.02 36.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.45 -0.796 . . . . 1.3200000000000001 110.273 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.606 ' CE2' ' HG2' ' A' ' 50' ' ' GLN . 4.2 m-85 -90.56 128.61 36.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.745 -0.661 . . . . 2.1400000000000001 110.005 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.645 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.5 t0 -77.54 154.24 32.61 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.242 -1.021 . . . . 1.75 108.242 172.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.768 HG13 ' HB2' ' A' ' 46' ' ' PHE . 39.8 t -112.43 133.12 59.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.257 0.551 . . . . 1.1000000000000001 111.068 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.616 HG21 ' HD2' ' B' ' 37' ' ' ARG . 0.4 OUTLIER -113.5 118.08 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.412 -0.813 . . . . 1.97 108.82 163.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.97 141.36 54.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.27 -0.877 . . . . 1.21 110.725 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.502 HG23 ' CA ' ' A' ' 46' ' ' PHE . 3.6 t -114.72 139.57 40.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.291 -0.868 . . . . 1.8500000000000001 109.671 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 3.0 tp10 -86.93 50.37 2.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.52 -0.309 . . . . 2.3999999999999999 111.326 -170.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 59.86 79.99 0.28 Allowed Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.977 -0.556 . . . . 2.1299999999999999 112.031 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.677 ' HG2' ' HB3' ' A' ' 42' ' ' PHE . 3.0 Cg_exo -67.86 159.15 54.12 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.439 2.093 . . . . 0.47999999999999998 112.188 175.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.74 -8.43 17.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.26 -0.882 . . . . 1.04 111.128 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.77 -67.22 0.55 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.827 -0.701 . . . . 0.23999999999999999 112.141 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.509 ' HA ' HG12 ' A' ' 24' ' ' ILE . 74.9 Cg_exo -48.66 120.5 5.32 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.111 2.54 . . . . 0.40999999999999998 112.503 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.724 ' HB1' HD22 ' A' ' 85' ' ' LEU . . . -147.1 139.65 24.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.241 0.543 . . . . 1.04 110.913 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.2 t -110.39 115.2 49.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.941 -0.763 . . . . 1.52 108.941 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.538 HD21 HG11 ' A' ' 83' ' ' VAL . 2.7 tt -110.08 119.73 40.23 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.625 0.726 . . . . 1.76 109.47 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.883 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 23.7 m -117.39 138.1 52.04 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.649 -1.159 . . . . 1.1200000000000001 110.36 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.633 HD12 HG12 ' A' ' 112' ' ' VAL . 3.9 mt -132.17 118.32 36.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.041 -0.527 . . . . 1.03 111.079 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -134.79 134.65 7.46 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.485 -0.864 . . . . 0.34999999999999998 112.294 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 16.1 tp -110.45 138.39 46.89 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.391 -0.596 . . . . 1.0600000000000001 109.391 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . -131.79 23.72 4.16 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 119.621 -1.276 . . . . 0.5 114.146 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 51.0 m-70 -159.69 -63.35 0.07 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.138 0.97 . . . . 2.5899999999999999 109.544 172.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER 176.58 -50.31 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.424 -1.716 . . . . 2.8700000000000001 107.842 -172.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.431 ' N ' ' HD2' ' A' ' 78' ' ' LYS . . . -109.93 -22.89 6.38 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.406 -0.816 . . . . 0.38 111.54 176.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.793 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -74.21 97.8 3.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.924 -0.31 . . . . 2.1299999999999999 110.446 -177.069 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.466 ' HG ' ' HB ' ' A' ' 101' ' ' VAL . 4.2 pp -115.59 151.22 35.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 2.0600000000000001 111.252 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.609 ' HB2' ' C ' ' B' ' 50' ' ' GLY . . . -125.22 132.45 52.98 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.677 -0.692 . . . . 1.1499999999999999 109.564 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.749 HG21 ' HE1' ' A' ' 36' ' ' HIS . 38.6 t -121.01 117.87 54.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.99 0.424 . . . . 2.0499999999999998 110.829 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.883 ' HB ' ' HB ' ' A' ' 72' ' ' THR . 86.4 t -101.38 126.74 55.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.934 -1.03 . . . . 1.98 109.729 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.724 HD22 ' HB1' ' A' ' 69' ' ' ALA . 3.5 tm? -122.55 123.45 41.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.349 -0.611 . . . . 1.8200000000000001 109.349 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.627 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 72.3 m-20 -118.62 110.59 17.5 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.574 -0.899 . . . . 1.8899999999999999 108.574 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.512 ' HB2' ' HB3' ' A' ' 65' ' ' PRO . 41.8 p90 -118.45 138.3 52.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.635 0.731 . . . . 0.93000000000000005 111.409 -173.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.872 ' HA ' HD12 ' A' ' 94' ' ' LEU . 20.4 m -73.11 131.6 42.26 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.942 -0.762 . . . . 1.02 108.942 171.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 46.2 mtp180 -95.2 145.43 25.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.104 0.478 . . . . 2.8399999999999999 111.799 -174.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 mt -71.95 -11.88 60.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.393 -0.821 . . . . 1.24 111.045 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -92.73 40.18 1.05 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.8 -0.636 . . . . 1.8200000000000001 111.129 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.03 28.44 17.23 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.505 0.503 . . . . 1.6000000000000001 111.911 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.701 ' HB3' ' HG3' ' B' ' 40' ' ' GLN . . . -150.4 -176.02 5.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.992 0.425 . . . . 1.0900000000000001 110.607 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.872 HD12 ' HA ' ' A' ' 88' ' ' THR . 5.9 tp -116.75 158.45 23.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.183 -1.043 . . . . 1.95 108.183 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -145.88 131.21 4.04 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.034 -1.226 . . . . 0.34999999999999998 110.034 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.68 ' CB ' ' HA ' ' B' ' 43' ' ' ARG . 18.0 m -123.4 146.65 47.82 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.2 -0.6 . . . . 1.6499999999999999 110.21 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' B' ' 37' ' ' ARG . . . -147.31 158.93 44.15 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.327 0.251 . . . . 1.0600000000000001 110.471 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.803 ' CB ' HG21 ' B' ' 44' ' ' ILE . . . -154.76 170.0 22.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.255 0.55 . . . . 1.03 112.29 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.781 ' HH ' HD13 ' A' ' 38' ' ' LEU . 16.9 p90 -152.9 156.92 39.86 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.15 -0.932 . . . . 0.79000000000000004 108.64 172.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.743 HG12 HG21 ' B' ' 52' ' ' VAL . 0.6 OUTLIER -133.0 144.05 37.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.881 -0.785 . . . . 1.8500000000000001 108.881 -177.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 80' ' ' ARG . 91.5 t -122.33 106.52 17.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.555 -0.748 . . . . 2.0099999999999998 109.467 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.643 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 15.8 mm-40 -62.47 -34.48 76.91 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.343 -1.299 . . . . 1.4299999999999999 112.031 -173.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -144.99 92.8 2.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.398 0.618 . . . . 1.0 110.662 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -75.62 -13.93 60.35 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.081 -0.963 . . . . 1.55 109.54 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.74 28.58 38.07 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.591 -0.731 . . . . 0.77000000000000002 113.176 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 78' ' ' LYS . 31.0 m -109.08 175.01 5.61 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.595 -0.52 . . . . 0.62 109.595 -173.721 -50.026 -35.397 -158.064 105.739 2.041 105.727 51.153 22.993 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.6 p -117.59 156.67 27.71 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.057 -0.349 . . . . 1.6899999999999999 110.057 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 p -46.74 140.76 4.33 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.526 0.565 . . . . 1.5 112.526 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.696 ' HB3' ' HG3' ' A' ' 14' ' ' GLU . 80.1 p 63.83 86.17 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.192 0.997 . . . . 1.25 112.611 171.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.475 ' HG3' ' CG1' ' A' ' 32' ' ' VAL . 1.5 pm0 -119.43 155.79 31.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.456 -1.247 . . . . 2.6400000000000001 110.148 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.1 116.07 27.1 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.886 0.374 . . . . 0.75 111.125 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.633 HG12 HD12 ' A' ' 73' ' ' ILE . 93.0 t -96.05 123.96 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.064 0.459 . . . . 1.9399999999999999 111.189 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 10' ' ' LYS . 32.8 t -104.18 115.27 30.11 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.879 -0.6 . . . . 1.1499999999999999 110.582 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.433 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . 20.8 m-85 -99.88 115.75 30.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.419 -0.585 . . . . 4.5300000000000002 109.419 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.534 ' HG2' ' HB2' ' A' ' 8' ' ' SER . 21.1 mt-30 -130.82 143.48 50.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.296 0.57 . . . . 1.3600000000000001 111.919 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.75 36.19 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.751 -0.94 . . . . 0.32000000000000001 110.751 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 121' ' ' ALA . 35.6 m -65.2 -18.11 23.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.906 0.384 . . . . 1.52 111.211 -175.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.85 -89.94 1.27 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.718 -0.674 . . . . 0.95999999999999996 112.818 173.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.9 t -161.16 156.58 24.54 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.582 -0.896 . . . . 1.6799999999999999 108.582 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.36 70.85 Favored Glycine 0 CA--C 1.506 -0.493 0 C-N-CA 120.517 -0.849 . . . . 0.89000000000000001 112.442 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . . . -65.91 133.78 51.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.669 0.271 . . . . 1.1200000000000001 111.248 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.758 HG21 ' HA ' ' A' ' 3' ' ' GLU . 41.4 p -147.01 132.78 18.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.808 -0.633 . . . . 1.0600000000000001 109.775 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 11' ' ' ALA . 7.7 tp -106.37 148.65 27.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.193 0.52 . . . . 1.71 111.118 -176.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.511 HG22 ' HG3' ' A' ' 1' ' ' LYS . 97.9 t -140.59 125.74 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.366 -0.834 . . . . 1.22 109.459 173.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.433 HG21 HD22 ' A' ' 19' ' ' LEU . 13.2 p -93.44 131.85 39.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.505 0.669 . . . . 2.0 110.434 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 18' ' ' GLN . 0.7 OUTLIER -124.29 179.59 4.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.491 -0.777 . . . . 1.29 110.755 -178.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.699 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 0.6 OUTLIER -103.54 156.36 17.83 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.711 -0.477 . . . . 1.1699999999999999 109.711 170.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.525 ' HB2' ' C ' ' A' ' 16' ' ' GLY . 11.7 tp -55.94 159.27 3.31 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.067 0.855 . . . . 2.02 111.279 -171.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.663 ' HA3' ' O ' ' B' ' 46' ' ' LEU . . . -75.15 -128.68 0.21 Allowed Glycine 0 CA--C 1.533 1.162 0 N-CA-C 114.53 0.572 . . . . 1.74 114.53 -169.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.765 ' H ' ' HA ' ' B' ' 47' ' ' ASP . 34.2 tt0 -163.82 141.48 7.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.303 0.483 . . . . 3.6000000000000001 112.303 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.6 m 82.51 97.7 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.241 1.016 . . . . 2.7000000000000002 113.27 172.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.908 ' HB3' HG21 ' B' ' 49' ' ' THR . 59.2 Cg_endo -73.3 144.38 36.81 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.582 2.855 . . . . 1.8799999999999999 113.749 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.407 HG21 ' HB3' ' B' ' 18' ' ' PRO . 2.3 m -175.29 114.41 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.439 0.695 . . . . 1.26 111.001 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.551 ' O ' ' HB ' ' B' ' 10' ' ' THR . . . -173.02 171.86 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.72 -0.845 . . . . 1.1599999999999999 108.72 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.769 ' HB ' ' H ' ' B' ' 13' ' ' ALA . 7.9 p -99.21 -28.25 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 113.419 0.896 . . . . 1.98 113.419 -170.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.56 ' H ' ' HG3' ' A' ' 102' ' ' GLU . 35.6 t . . . . . 0 C--O 1.25 1.112 0 O-C-N 123.753 0.658 . . . . 2.0499999999999998 109.302 -167.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.252 -0.277 . . . . 7.6299999999999999 110.252 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.6 p -77.68 82.9 4.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 4.9800000000000004 112.354 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -131.1 -63.61 0.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.309 -0.86 . . . . 3.7000000000000002 109.553 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.551 ' HB ' ' O ' ' A' ' 134' ' ' ALA . 2.6 p -87.5 146.83 40.42 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.029 -0.987 . . . . 1.6599999999999999 112.384 -174.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.519 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 72.6 Cg_endo -78.24 156.27 29.46 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.158 2.572 . . . . 0.77000000000000002 110.999 172.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' B' ' 15' ' ' SER . . . -63.94 110.85 2.25 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.035 -0.728 . . . . 1.3400000000000001 109.035 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.769 ' H ' ' HB ' ' A' ' 135' ' ' VAL . . . -46.27 -78.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.6 0.563 . . . . 1.1000000000000001 112.426 -167.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' CYS . . . . . 0.471 ' HB2' ' HG3' ' B' ' 29' ' ' GLU . 0.5 OUTLIER -65.79 -25.55 67.29 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.219 -0.301 . . . . 0.60999999999999999 111.618 -175.087 -141.968 43.565 -175.268 103.422 2.034 103.815 -98.847 169.908 3 3 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' SER . . . . . 0.591 ' HB3' ' HB2' ' B' ' 12' ' ' ALA . 39.8 t -72.94 -29.84 63.4 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.884 0.327 . . . . 2.1200000000000001 111.884 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' B' ' 17' ' ' ASN . 43.8 p -88.55 -10.62 48.23 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.943 0.401 . . . . 0.62 111.648 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' B' ' 16' ' ' SER . 12.7 m120 79.12 71.28 0.17 Allowed Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 115.165 -0.925 . . . . 1.99 111.007 174.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' B' ' 20' ' ' GLY . 76.1 Cg_endo -91.19 -61.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.251 2.634 . . . . 0.40000000000000002 111.527 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' CYS . . . . . 0.43 ' H ' ' CG ' ' B' ' 18' ' ' PRO . 0.0 OUTLIER -86.75 31.52 0.69 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.815 0.817 . . . . 1.04 108.98 173.956 -22.012 -91.664 -52.767 103.516 2.026 103.496 -49.262 -61.909 3 3 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' B' ' 21' ' ' PRO . . . -127.65 41.51 1.58 Allowed Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.496 -1.229 . . . . 0.64000000000000001 114.031 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.573 ' HD2' ' HB1' ' B' ' 24' ' ' ALA . 30.3 Cg_endo -68.8 -172.25 0.46 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 CA-C-N 119.706 1.753 . . . . 1.1699999999999999 111.009 169.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.61 5.09 6.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.376 0.608 . . . . 2.4399999999999999 109.809 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ALA . . . . . 0.518 ' HB1' ' CD1' ' B' ' 42' ' ' TYR . . . -115.03 -50.35 2.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.441 -0.799 . . . . 1.1000000000000001 112.243 -175.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.723 ' HB2' ' HB2' ' B' ' 54' ' ' CYS . . . -63.22 166.17 6.49 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.654 0.983 . . . . 1.1000000000000001 113.654 -167.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.31 -42.3 1.18 Allowed Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 114.122 -1.399 . . . . 0.39000000000000001 113.243 -171.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' B' ' 37' ' ' ARG . 0.2 OUTLIER -144.63 150.43 37.4 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 117.253 0.526 . . . . 1.0800000000000001 112.189 -174.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 14.7 t -133.85 136.95 44.74 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.648 -0.705 . . . . 0.35999999999999999 110.03 178.708 169.908 -98.847 -175.268 103.815 2.034 103.422 43.565 -141.968 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . 0.687 ' HD3' HD13 ' B' ' 35' ' ' ILE . 39.6 tttm -146.3 115.22 6.92 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 122.12 0.168 . . . . 1.9099999999999999 110.995 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . 0.662 ' HG2' ' HB2' ' B' ' 13' ' ' ALA . 11.5 mt-10 -76.44 141.07 41.49 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.767 -0.583 . . . . 1.8300000000000001 110.547 175.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.8 p -115.7 -166.48 1.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.835 -0.62 . . . . 0.56000000000000005 110.738 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -91.4 -5.71 54.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.53 -0.544 . . . . 2.2200000000000002 109.53 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' SER . . . . . 0.686 ' HB3' HG11 ' A' ' 101' ' ' VAL . 12.9 m -133.62 21.03 3.91 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 116.006 -0.543 . . . . 2.0600000000000001 111.584 -174.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.97 -119.03 1.75 Allowed Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 108.702 -1.759 . . . . 0.77000000000000002 108.702 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' TYR . . . . . 0.664 ' OH ' ' HB3' ' B' ' 51' ' ' ASN . 0.5 OUTLIER -155.08 168.09 28.19 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.42 0.629 . . . . 2.1499999999999999 111.203 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . 0.687 HD13 ' HD3' ' B' ' 28' ' ' LYS . 44.1 mt -121.15 140.53 45.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.494 -1.23 . . . . 1.1399999999999999 108.83 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . 0.583 ' SG ' HG23 ' B' ' 52' ' ' VAL . 72.8 m -122.21 151.89 40.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.164 0.507 . . . . 0.94999999999999996 110.182 179.042 -61.909 -49.262 -52.767 103.496 2.026 103.516 -91.664 -22.012 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ARG . . . . . 0.616 ' HD2' HG21 ' A' ' 60' ' ' VAL . 4.8 mtp85 -142.71 137.56 29.94 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.132 -0.692 . . . . 2.1099999999999999 109.132 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' CYS . . . . . 0.807 ' SG ' HG12 ' B' ' 44' ' ' ILE . 83.2 m -97.44 170.59 8.95 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.246 1.022 . . . . 0.26000000000000001 112.908 -176.818 -59.297 -35.081 -96.036 103.171 2.024 102.627 -84.985 -66.456 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASN . . . . . 0.616 ' HB3' ' CD2' ' B' ' 42' ' ' TYR . 23.0 t-20 -91.64 177.38 6.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.133 -1.848 . . . . 0.72999999999999998 108.619 175.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLN . . . . . 0.701 ' HG3' ' HB3' ' A' ' 93' ' ' ALA . 50.4 tt0 -47.91 -52.2 20.33 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.772 0.656 . . . . 2.0099999999999998 112.772 -176.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.52 17.31 44.88 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.857 -0.687 . . . . 0.46999999999999997 114.148 -172.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.616 ' CD2' ' HB3' ' B' ' 39' ' ' ASN . 24.9 m-85 -134.59 156.17 49.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.504 1.152 . . . . 0.64000000000000001 112.021 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.68 ' HA ' ' CB ' ' A' ' 96' ' ' SER . 40.5 mtt180 -128.99 161.89 28.87 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.948 -1.478 . . . . 1.5900000000000001 108.768 173.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.881 ' HB ' HG11 ' A' ' 84' ' ' VAL . 2.5 mm -85.37 124.95 40.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.069 -0.514 . . . . 1.0800000000000001 111.601 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -104.4 114.19 28.26 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.986 -0.746 . . . . 1.5800000000000001 108.986 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.663 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 0.5 OUTLIER -82.29 148.09 28.53 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.718 -0.674 . . . . 1.6599999999999999 109.863 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . 0.765 ' HA ' ' H ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -96.19 -175.7 3.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.215 1.007 . . . . 2.5699999999999998 112.589 -171.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . 0.499 ' HA2' ' HG ' ' A' ' 128' ' ' LEU . . . -89.23 23.11 19.84 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 113.985 -1.462 . . . . 0.83999999999999997 111.657 -170.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.908 HG21 ' HB3' ' A' ' 132' ' ' PRO . 23.3 p -137.6 -29.25 0.87 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.329 -0.435 . . . . 1.7 110.204 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . 0.609 ' C ' ' HB2' ' A' ' 82' ' ' ALA . . . 125.87 34.99 0.61 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.94 -0.648 . . . . 0.56999999999999995 111.857 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.664 ' HB3' ' OH ' ' B' ' 34' ' ' TYR . 12.5 m120 -121.3 179.51 4.39 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.041 -1.096 . . . . 3.0699999999999998 108.041 177.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.743 HG21 HG12 ' A' ' 100' ' ' VAL . 8.7 m -148.43 149.86 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.208 0.818 . . . . 1.8600000000000001 113.208 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.7 t -159.07 165.73 33.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.432 -0.804 . . . . 1.0800000000000001 109.962 173.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' CYS . . . . . 0.723 ' HB2' ' HB2' ' B' ' 24' ' ' ALA . 92.3 m -99.36 138.01 37.06 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.304 1.224 . . . . 0.75 114.304 -169.395 -66.456 -84.985 -96.036 102.627 2.024 103.171 -35.081 -59.297 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . . . . . . . . . 6.0 pt -142.48 169.68 12.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 CA-C-N 114.314 -1.312 . . . . 1.1899999999999999 109.859 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' VAL . . . . . . . . . . . . . 1.1 m -43.3 134.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 122.557 1.17 . . . . 1.96 111.804 -175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.512 ' HD2' HD21 ' A' ' 94' ' ' LEU . 18.6 ptt180 -62.83 116.56 5.36 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.389 -1.732 . . . . 4.4100000000000001 112.529 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.451 ' N ' ' HD2' ' B' ' 43' ' ' ARG . 17.6 pt20 -138.0 -49.23 0.56 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.047 -0.524 . . . . 2.4500000000000002 110.411 167.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 58' ' ' GLN . 33.7 tt0 164.25 113.57 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.677 0.791 . . . . 2.1200000000000001 109.111 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m 58.65 52.74 6.56 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.433 -0.951 . . . . 1.99 108.433 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.135 0 CA-C-O 118.566 -1.13 . . . . 1.24 110.327 -170.415 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.634 ' HE2' ' CB ' ' A' ' 122' ' ' THR . 80.9 tttt . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.693 0.282 . . . . 1.06 110.566 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 m -92.72 95.61 9.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.213 -0.449 . . . . 0.72 110.115 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.786 ' HA ' HG22 ' A' ' 122' ' ' THR . 28.9 mt-10 -87.77 113.27 23.28 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.532 0.682 . . . . 1.14 110.595 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.711 HG21 ' HB ' ' A' ' 9' ' ' THR . 3.6 mm -81.37 -61.28 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.892 -1.049 . . . . 1.14 110.46 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 54.79 57.61 5.54 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.894 -0.594 . . . . 3.14 110.577 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 117' ' ' VAL . . . -153.97 -156.61 7.73 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.361 -0.923 . . . . 1.61 111.333 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.555 ' C ' HG22 ' A' ' 117' ' ' VAL . 7.6 m-20 -104.2 -17.79 14.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.185 0.492 . . . . 2.36 111.577 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.569 ' HB2' ' HG2' ' A' ' 115' ' ' GLN . 20.0 p -160.74 157.52 27.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.163 0.506 . . . . 0.95 111.174 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.711 ' HB ' HG21 ' A' ' 4' ' ' ILE . 11.8 t -153.05 165.33 35.93 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.069 -0.969 . . . . 0.8 109.394 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 113' ' ' SER . 52.6 mtpt -139.84 134.56 31.89 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.356 0.598 . . . . 1.03 110.877 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.462 ' HB2' HD21 ' A' ' 123' ' ' LEU . . . -122.66 167.17 13.77 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.04 -0.982 . . . . 0.51 110.07 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.6 m -108.13 112.38 24.88 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.679 -0.691 . . . . 0.5 109.245 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 109' ' ' SER . 54.8 tp -84.28 154.6 22.86 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.169 -1.049 . . . . 1.23 108.169 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.698 ' HG3' ' HB3' ' A' ' 109' ' ' SER . 34.7 tt0 -150.13 141.37 23.17 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.359 0.6 . . . . 0.86 109.539 174.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 4.2 tm-20 -58.31 111.42 1.21 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.487 -1.233 . . . . 1.28 108.863 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' C ' ' HB2' ' A' ' 128' ' ' LEU . . . 107.64 -4.69 34.69 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 119.745 -1.217 . . . . 0.31 111.904 -171.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.702 ' HA ' ' HA ' ' A' ' 127' ' ' THR . 37.3 mt-30 -128.96 160.68 31.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.472 . . . . 1.22 110.728 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.476 ' CG ' ' HA ' ' A' ' 128' ' ' LEU . 1.7 mt-30 -123.59 161.66 24.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.425 -0.807 . . . . 1.2 109.128 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' O ' ' HA ' ' A' ' 72' ' ' THR . 11.4 mt -128.82 114.46 16.57 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.822 -0.436 . . . . 1.29 109.822 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.8 m -101.99 133.23 47.14 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.171 0.51 . . . . 0.48 111.215 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 56.1 tp -122.57 115.09 21.56 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.798 -0.637 . . . . 1.24 111.125 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.46 HG23 HG23 ' A' ' 70' ' ' VAL . 2.6 m -93.98 99.7 11.98 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.023 -0.732 . . . . 0.37 109.023 170.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.678 ' CZ ' HD22 ' A' ' 28' ' ' LEU . 8.9 p90 -124.02 169.04 12.04 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.399 -0.593 . . . . 1.79 109.399 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 68' ' ' PRO . 37.5 mt -124.68 102.14 10.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.355 -0.609 . . . . 0.2 109.355 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB3' ' HE2' ' A' ' 23' ' ' PHE . 16.9 t -134.88 170.56 15.68 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.517 -0.765 . . . . 1.13 110.296 -175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.684 ' HB ' ' HG ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -127.0 -3.58 6.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.299 -0.864 . . . . 0.48 110.69 174.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HE2' ' HB2' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -170.96 71.32 0.05 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.661 -0.7 . . . . 1.35 109.261 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.678 HD22 ' CZ ' ' A' ' 23' ' ' PHE . 0.5 OUTLIER -89.62 133.88 34.41 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.842 -0.617 . . . . 1.35 110.97 -176.173 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -121.79 126.11 48.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.118 0.485 . . . . 2.05 110.111 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.466 HG22 HD21 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -130.83 155.05 41.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.209 -0.596 . . . . 0.36 110.89 -177.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.54 142.72 33.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.901 -1.045 . . . . 0.29 109.835 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.657 ' HB ' ' HB3' ' A' ' 36' ' ' HIS . 62.9 t -106.7 133.75 50.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.328 -0.851 . . . . 0.71 110.566 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.93 65.55 0.88 Allowed Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.717 -0.674 . . . . 1.09 114.507 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -173.87 -71.53 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.687 -1.597 . . . . 3.1 106.687 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.5 OUTLIER -161.35 106.39 1.33 Allowed 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.727 -0.669 . . . . 1.94 110.679 162.785 22.993 51.153 -158.064 105.727 2.041 105.739 -35.397 -50.026 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.756 ' HE1' HG21 ' A' ' 83' ' ' VAL . 15.2 t-160 -175.03 136.67 0.39 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.681 -0.859 . . . . 2.23 108.681 168.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.11 145.24 23.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 118.732 0.696 . . . . 1.25 109.951 171.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -151.97 161.2 43.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.113 0.483 . . . . 1.34 111.231 -179.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.8 112.69 18.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.085 -0.961 . . . . 0.37 109.039 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -82.17 87.84 6.5 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.88 -0.785 . . . . 0.19 108.88 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.601 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 14.2 m-80 -78.93 65.94 4.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.482 -0.781 . . . . 1.74 109.941 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.66 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 23.1 m-85 -56.26 -45.56 80.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.091 -0.958 . . . . 1.25 111.561 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.684 ' HG ' ' HB ' ' A' ' 26' ' ' THR . 60.7 mt -57.09 -53.61 56.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 1.44 112.196 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.77 -19.87 64.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.898 0.856 . . . . 1.79 109.577 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.67 44.06 7.01 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.479 -1.237 . . . . 0.44 112.438 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.682 ' HB2' ' CG1' ' A' ' 59' ' ' VAL . 13.8 p90 -152.17 148.24 27.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.041 0.448 . . . . 1.28 110.561 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.684 ' HB3' HG13 ' A' ' 60' ' ' VAL . 2.0 tp -114.11 113.77 25.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.036 -0.529 . . . . 0.26 110.571 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 13.5 tttt -104.96 134.76 47.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.455 -0.339 . . . . 1.32 110.776 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 37.6 p90 -146.63 141.27 26.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.854 -0.339 . . . . 1.24 111.892 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.612 ' HG2' ' CE2' ' A' ' 57' ' ' PHE . 9.6 pt20 -121.87 162.15 21.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.037 0.446 . . . . 1.22 110.554 176.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.772 HG21 HG11 ' A' ' 101' ' ' VAL . 3.0 p -131.48 102.28 5.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.919 -0.582 . . . . 0.58 110.839 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.29 -172.42 22.72 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.714 -0.955 . . . . 1.8 110.714 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -74.24 -75.46 0.16 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.241 0.52 . . . . 3.66 110.056 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -104.98 109.07 20.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.844 -0.798 . . . . 4.91 108.844 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 50' ' ' GLN . 15.0 m -151.98 158.76 43.54 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.211 -0.449 . . . . 2.19 110.373 -176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.64 139.02 36.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.45 -0.796 . . . . 0.61 110.273 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.612 ' CE2' ' HG2' ' A' ' 50' ' ' GLN . 4.2 m-85 -90.56 128.61 36.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.745 -0.661 . . . . 1.24 110.005 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.5 t0 -77.54 154.24 32.61 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.242 -1.021 . . . . 1.75 108.242 172.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.682 ' CG1' ' HB2' ' A' ' 46' ' ' PHE . 39.8 t -112.43 133.12 59.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.257 0.551 . . . . 0.39 111.068 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.789 ' HB ' HG21 ' B' ' 35' ' ' ILE . 0.4 OUTLIER -113.5 118.08 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.412 -0.813 . . . . 1.32 108.82 163.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.97 141.36 54.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.27 -0.877 . . . . 1.21 110.725 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.626 HG11 ' HG3' ' A' ' 65' ' ' PRO . 3.6 t -114.72 139.57 40.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.291 -0.868 . . . . 1.19 109.671 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 3.0 tp10 -86.93 50.37 2.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.52 -0.309 . . . . 2.4 111.326 -170.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 59.86 79.99 0.28 Allowed Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.977 -0.556 . . . . 2.13 112.031 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.66 ' HG2' ' HB3' ' A' ' 42' ' ' PHE . 3.0 Cg_exo -67.86 159.15 54.12 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.439 2.093 . . . . 0.36 112.188 175.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.74 -8.43 17.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.26 -0.882 . . . . 0.39 111.128 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.77 -67.22 0.55 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.827 -0.701 . . . . 0.2 112.141 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.479 ' HA ' HG12 ' A' ' 24' ' ' ILE . 74.9 Cg_exo -48.66 120.5 5.32 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.111 2.54 . . . . 0.27 112.503 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.694 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -147.1 139.65 24.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.241 0.543 . . . . 0.25 110.913 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.2 t -110.39 115.2 49.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.941 -0.763 . . . . 0.91 108.941 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.564 HD21 HG13 ' A' ' 83' ' ' VAL . 2.7 tt -110.08 119.73 40.23 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.625 0.726 . . . . 1.14 109.47 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.886 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 23.7 m -117.39 138.1 52.04 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.649 -1.159 . . . . 0.4 110.36 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.656 HD13 HG11 ' A' ' 112' ' ' VAL . 3.9 mt -132.17 118.32 36.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.041 -0.527 . . . . 0.51 111.079 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -134.79 134.65 7.46 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.485 -0.864 . . . . 0.3 112.294 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 16.1 tp -110.45 138.39 46.89 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.391 -0.596 . . . . 0.31 109.391 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . -131.79 23.72 4.16 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 119.621 -1.276 . . . . 0.49 114.146 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.435 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 51.0 m-70 -159.69 -63.35 0.07 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.138 0.97 . . . . 1.93 109.544 172.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER 176.58 -50.31 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.424 -1.716 . . . . 2.24 107.842 -172.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 78' ' ' LYS . . . -109.93 -22.89 6.38 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.406 -0.816 . . . . 0.38 111.54 176.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -74.21 97.8 3.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.924 -0.31 . . . . 1.65 110.446 -177.069 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' HG ' ' HB ' ' A' ' 101' ' ' VAL . 4.2 pp -115.59 151.22 35.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 1.4 111.252 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.609 ' HB2' ' C ' ' B' ' 50' ' ' GLY . . . -125.22 132.45 52.98 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.677 -0.692 . . . . 0.34 109.564 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.756 HG21 ' HE1' ' A' ' 36' ' ' HIS . 38.6 t -121.01 117.87 54.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.99 0.424 . . . . 1.36 110.829 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.891 HG13 ' HB ' ' B' ' 44' ' ' ILE . 86.4 t -101.38 126.74 55.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.934 -1.03 . . . . 1.25 109.729 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.694 HD21 ' HB1' ' A' ' 69' ' ' ALA . 3.5 tm? -122.55 123.45 41.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.349 -0.611 . . . . 1.2 109.349 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 72.3 m-20 -118.62 110.59 17.5 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.574 -0.899 . . . . 1.89 108.574 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.527 ' HB2' ' HB3' ' A' ' 65' ' ' PRO . 41.8 p90 -118.45 138.3 52.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.635 0.731 . . . . 0.24 111.409 -173.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.882 ' HA ' HD12 ' A' ' 94' ' ' LEU . 20.4 m -73.11 131.6 42.26 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.942 -0.762 . . . . 0.33 108.942 171.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 46.2 mtp180 -95.2 145.43 25.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.104 0.478 . . . . 2.2 111.799 -174.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 mt -71.95 -11.88 60.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.393 -0.821 . . . . 0.56 111.045 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -92.73 40.18 1.05 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.8 -0.636 . . . . 1.57 111.129 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.03 28.44 17.23 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.505 0.503 . . . . 1.1 111.911 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.691 ' HB1' ' HG3' ' B' ' 40' ' ' GLN . . . -150.4 -176.02 5.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.992 0.425 . . . . 0.44 110.607 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.882 HD12 ' HA ' ' A' ' 88' ' ' THR . 5.9 tp -116.75 158.45 23.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.183 -1.043 . . . . 1.26 108.183 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.405 ' N ' ' HG ' ' A' ' 94' ' ' LEU . . . -145.88 131.21 4.04 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.034 -1.226 . . . . 0.29 110.034 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.693 ' CB ' ' HA ' ' B' ' 43' ' ' ARG . 18.0 m -123.4 146.65 47.82 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.2 -0.6 . . . . 1.32 110.21 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' B' ' 37' ' ' ARG . . . -147.31 158.93 44.15 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.327 0.251 . . . . 0.6 110.471 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.8 ' CB ' HG21 ' B' ' 44' ' ' ILE . . . -154.76 170.0 22.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.255 0.55 . . . . 0.17 112.29 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.539 ' HB3' HG12 ' B' ' 35' ' ' ILE . 16.9 p90 -152.9 156.92 39.86 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.15 -0.932 . . . . 0.38 108.64 172.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.719 ' CG1' HG22 ' B' ' 52' ' ' VAL . 0.6 OUTLIER -133.0 144.05 37.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.881 -0.785 . . . . 1.22 108.881 -177.474 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.8 ' O ' ' HA ' ' A' ' 80' ' ' ARG . 91.5 t -122.33 106.52 17.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.555 -0.748 . . . . 1.36 109.467 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.671 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 15.8 mm-40 -62.47 -34.48 76.91 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.343 -1.299 . . . . 1.43 112.031 -173.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -144.99 92.8 2.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.398 0.618 . . . . 1.0 110.662 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -75.62 -13.93 60.35 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.081 -0.963 . . . . 1.36 109.54 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.74 28.58 38.07 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.591 -0.731 . . . . 0.77 113.176 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 78' ' ' LYS . 31.0 m -109.08 175.01 5.61 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.595 -0.52 . . . . 0.62 109.595 -173.721 -50.026 -35.397 -158.064 105.739 2.041 105.727 51.153 22.993 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.6 p -117.59 156.67 27.71 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.057 -0.349 . . . . 1.69 110.057 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 p -46.74 140.76 4.33 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.526 0.565 . . . . 1.14 112.526 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.698 ' HB3' ' HG3' ' A' ' 14' ' ' GLU . 80.1 p 63.83 86.17 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.192 0.997 . . . . 0.51 112.611 171.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.495 ' HG3' ' CG1' ' A' ' 32' ' ' VAL . 1.5 pm0 -119.43 155.79 31.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.456 -1.247 . . . . 2.64 110.148 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.1 116.07 27.1 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.886 0.374 . . . . 0.75 111.125 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.656 HG11 HD13 ' A' ' 73' ' ' ILE . 93.0 t -96.05 123.96 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.064 0.459 . . . . 1.15 111.189 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.454 ' HA ' ' HG2' ' A' ' 10' ' ' LYS . 32.8 t -104.18 115.27 30.11 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.879 -0.6 . . . . 0.71 110.582 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.442 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . 20.8 m-85 -99.88 115.75 30.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.419 -0.585 . . . . 3.65 109.419 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.569 ' HG2' ' HB2' ' A' ' 8' ' ' SER . 91.0 mt-30 -130.82 143.48 50.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.296 0.57 . . . . 1.36 111.919 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.75 36.19 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.751 -0.94 . . . . 0.32 110.751 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 121' ' ' ALA . 35.6 m -65.2 -18.11 23.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.906 0.384 . . . . 0.86 111.211 -175.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.85 -89.94 1.27 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.718 -0.674 . . . . 0.96 112.818 173.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.9 t -161.16 156.58 24.54 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.582 -0.896 . . . . 1.36 108.582 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.36 70.85 Favored Glycine 0 CA--C 1.506 -0.493 0 C-N-CA 120.517 -0.849 . . . . 0.5 112.442 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.617 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -65.91 133.78 51.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.669 0.271 . . . . 0.4 111.248 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.786 HG22 ' HA ' ' A' ' 3' ' ' GLU . 41.4 p -147.01 132.78 18.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.808 -0.633 . . . . 0.49 109.775 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 11' ' ' ALA . 7.7 tp -106.37 148.65 27.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.193 0.52 . . . . 1.09 111.118 -176.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.511 HG22 ' HG3' ' A' ' 1' ' ' LYS . 97.9 t -140.59 125.74 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.366 -0.834 . . . . 0.55 109.459 173.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.485 HG23 HD23 ' A' ' 19' ' ' LEU . 13.2 p -93.44 131.85 39.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.505 0.669 . . . . 1.22 110.434 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 18' ' ' GLN . 0.7 OUTLIER -124.29 179.59 4.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.491 -0.777 . . . . 0.59 110.755 -178.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.702 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 0.6 OUTLIER -103.54 156.36 17.83 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.711 -0.477 . . . . 0.47 109.711 170.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.539 ' HB2' ' C ' ' A' ' 16' ' ' GLY . 11.7 tp -55.94 159.27 3.31 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.067 0.855 . . . . 1.44 111.279 -171.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' B' ' 46' ' ' LEU . . . -75.15 -128.68 0.21 Allowed Glycine 0 CA--C 1.533 1.162 0 N-CA-C 114.53 0.572 . . . . 1.74 114.53 -169.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.765 ' H ' ' HA ' ' B' ' 47' ' ' ASP . 34.2 tt0 -163.82 141.48 7.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.303 0.483 . . . . 3.6 112.303 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.6 m 82.51 97.7 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.241 1.016 . . . . 2.45 113.27 172.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.83 ' HB3' HG21 ' B' ' 49' ' ' THR . 59.2 Cg_endo -73.3 144.38 36.81 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.582 2.855 . . . . 1.42 113.749 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.421 HG22 ' HB3' ' B' ' 18' ' ' PRO . 2.3 m -175.29 114.41 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.439 0.695 . . . . 1.26 111.001 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.567 ' O ' ' HB ' ' B' ' 10' ' ' THR . . . -173.02 171.86 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.72 -0.845 . . . . 0.53 108.72 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.848 ' HB ' ' H ' ' B' ' 13' ' ' ALA . 7.9 p -99.21 -28.25 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 113.419 0.896 . . . . 1.98 113.419 -170.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.655 ' H ' ' HG3' ' A' ' 102' ' ' GLU . 35.6 t . . . . . 0 C--O 1.25 1.112 0 O-C-N 123.753 0.658 . . . . 1.67 109.302 -167.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.252 -0.277 . . . . 7.26 110.252 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.6 p -77.68 82.9 4.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 4.69 112.354 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -131.1 -63.61 0.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.309 -0.86 . . . . 3.7 109.553 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 134' ' ' ALA . 2.6 p -87.5 146.83 40.42 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.029 -0.987 . . . . 1.42 112.384 -174.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.535 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 72.6 Cg_endo -78.24 156.27 29.46 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.158 2.572 . . . . 0.7 110.999 172.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' B' ' 15' ' ' SER . . . -63.94 110.85 2.25 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.035 -0.728 . . . . 0.65 109.035 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.848 ' H ' ' HB ' ' A' ' 135' ' ' VAL . . . -46.27 -78.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.6 0.563 . . . . 0.46 112.426 -167.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' CYS . . . . . 0.486 ' HB2' ' HG3' ' B' ' 29' ' ' GLU . 0.5 OUTLIER -65.79 -25.55 67.29 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.219 -0.301 . . . . 0.6 111.618 -175.087 -141.968 43.565 -175.268 103.422 2.034 103.815 -98.847 169.908 3 3 . 1 . 001 nuclear build full ' B' B ' 15' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' B' ' 12' ' ' ALA . 39.8 t -72.94 -29.84 63.4 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.884 0.327 . . . . 1.5 111.884 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' B' ' 17' ' ' ASN . 43.8 p -88.55 -10.62 48.23 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.943 0.401 . . . . 0.57 111.648 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' B' ' 16' ' ' SER . 12.7 m120 79.12 71.28 0.17 Allowed Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 115.165 -0.925 . . . . 1.54 111.007 174.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.445 ' HB2' ' CE2' ' B' ' 34' ' ' TYR . 76.1 Cg_endo -91.19 -61.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.251 2.634 . . . . 0.33 111.527 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.75 31.52 0.69 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.815 0.817 . . . . 1.04 108.98 173.956 -22.012 -91.664 -52.767 103.516 2.026 103.496 -49.262 -61.909 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' B' ' 21' ' ' PRO . . . -127.65 41.51 1.58 Allowed Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.496 -1.229 . . . . 0.64 114.031 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' B' ' 24' ' ' ALA . 30.3 Cg_endo -68.8 -172.25 0.46 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 CA-C-N 119.706 1.753 . . . . 1.17 111.009 169.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.61 5.09 6.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.376 0.608 . . . . 2.44 109.809 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ALA . . . . . 0.49 ' HB1' ' CD1' ' B' ' 42' ' ' TYR . . . -115.03 -50.35 2.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.441 -0.799 . . . . 0.4 112.243 -175.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' B' ' 54' ' ' CYS . . . -63.22 166.17 6.49 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.654 0.983 . . . . 0.29 113.654 -167.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.31 -42.3 1.18 Allowed Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 114.122 -1.399 . . . . 0.39 113.243 -171.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.634 ' HB ' ' HB2' ' B' ' 37' ' ' ARG . 0.2 OUTLIER -144.63 150.43 37.4 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 117.253 0.526 . . . . 0.26 112.189 -174.152 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 14.7 t -133.85 136.95 44.74 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.648 -0.705 . . . . 0.36 110.03 178.708 169.908 -98.847 -175.268 103.815 2.034 103.422 43.565 -141.968 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LYS . . . . . 0.534 ' HD3' ' CD1' ' B' ' 35' ' ' ILE . 39.6 tttm -146.3 115.22 6.92 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 122.12 0.168 . . . . 1.39 110.995 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . 0.748 ' HG2' ' HB3' ' B' ' 13' ' ' ALA . 11.5 mt-10 -76.44 141.07 41.49 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.767 -0.583 . . . . 1.83 110.547 175.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.8 p -115.7 -166.48 1.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.835 -0.62 . . . . 0.5 110.738 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -91.4 -5.71 54.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.53 -0.544 . . . . 1.67 109.53 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' SER . . . . . 0.694 ' HB3' HG13 ' A' ' 101' ' ' VAL . 12.9 m -133.62 21.03 3.91 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 116.006 -0.543 . . . . 1.59 111.584 -174.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.97 -119.03 1.75 Allowed Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 108.702 -1.759 . . . . 0.51 108.702 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' TYR . . . . . 0.667 ' OH ' ' HB3' ' B' ' 51' ' ' ASN . 0.5 OUTLIER -155.08 168.09 28.19 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.42 0.629 . . . . 1.23 111.203 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.789 HG21 ' HB ' ' A' ' 60' ' ' VAL . 44.1 mt -121.15 140.53 45.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.494 -1.23 . . . . 0.25 108.83 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' CYS . . . . . 0.635 ' SG ' HG23 ' B' ' 52' ' ' VAL . 72.8 m -122.21 151.89 40.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.164 0.507 . . . . 0.95 110.182 179.042 -61.909 -49.262 -52.767 103.496 2.026 103.516 -91.664 -22.012 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ARG . . . . . 0.636 ' HD2' HG23 ' A' ' 60' ' ' VAL . 4.8 mtp85 -142.71 137.56 29.94 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.132 -0.692 . . . . 1.73 109.132 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' CYS . . . . . 0.784 ' SG ' HG12 ' B' ' 44' ' ' ILE . 83.2 m -97.44 170.59 8.95 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.246 1.022 . . . . 0.26 112.908 -176.818 -59.297 -35.081 -96.036 103.171 2.024 102.627 -84.985 -66.456 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASN . . . . . 0.626 ' HB3' ' CD2' ' B' ' 42' ' ' TYR . 23.0 t-20 -91.64 177.38 6.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.133 -1.848 . . . . 0.65 108.619 175.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLN . . . . . 0.691 ' HG3' ' HB1' ' A' ' 93' ' ' ALA . 50.4 tt0 -47.91 -52.2 20.33 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.772 0.656 . . . . 1.53 112.772 -176.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.52 17.31 44.88 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.857 -0.687 . . . . 0.45 114.148 -172.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.626 ' CD2' ' HB3' ' B' ' 39' ' ' ASN . 24.9 m-85 -134.59 156.17 49.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.504 1.152 . . . . 0.4 112.021 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.693 ' HA ' ' CB ' ' A' ' 96' ' ' SER . 40.5 mtt180 -128.99 161.89 28.87 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.948 -1.478 . . . . 1.09 108.768 173.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.891 ' HB ' HG13 ' A' ' 84' ' ' VAL . 2.5 mm -85.37 124.95 40.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.069 -0.514 . . . . 0.23 111.601 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -104.4 114.19 28.26 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.986 -0.746 . . . . 0.92 108.986 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.667 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 0.5 OUTLIER -82.29 148.09 28.53 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.863 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ASP . . . . . 0.765 ' HA ' ' H ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -96.19 -175.7 3.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.215 1.007 . . . . 2.57 112.589 -171.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLY . . . . . 0.511 ' HA2' ' HG ' ' A' ' 128' ' ' LEU . . . -89.23 23.11 19.84 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 113.985 -1.462 . . . . 0.84 111.657 -170.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.83 HG21 ' HB3' ' A' ' 132' ' ' PRO . 23.3 p -137.6 -29.25 0.87 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.329 -0.435 . . . . 0.97 110.204 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLY . . . . . 0.609 ' C ' ' HB2' ' A' ' 82' ' ' ALA . . . 125.87 34.99 0.61 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.94 -0.648 . . . . 0.53 111.857 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.667 ' HB3' ' OH ' ' B' ' 34' ' ' TYR . 12.5 m120 -121.3 179.51 4.39 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.041 -1.096 . . . . 2.35 108.041 177.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.719 HG22 ' CG1' ' A' ' 100' ' ' VAL . 8.7 m -148.43 149.86 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.208 0.818 . . . . 1.2 113.208 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.7 t -159.07 165.73 33.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.432 -0.804 . . . . 0.31 109.962 173.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' CYS . . . . . 0.705 ' HB2' ' HB2' ' B' ' 24' ' ' ALA . 92.3 m -99.36 138.01 37.06 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.304 1.224 . . . . 0.75 114.304 -169.395 -66.456 -84.985 -96.036 102.627 2.024 103.171 -35.081 -59.297 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ILE . . . . . . . . . . . . . 6.0 pt -142.48 169.68 12.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 CA-C-N 114.314 -1.312 . . . . 0.48 109.859 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' VAL . . . . . 0.403 HG13 ' H ' ' B' ' 56' ' ' VAL . 1.1 m -43.3 134.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 122.557 1.17 . . . . 1.3 111.804 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.514 ' HD2' HD22 ' A' ' 94' ' ' LEU . 18.6 ptt180 -62.83 116.56 5.36 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.389 -1.732 . . . . 3.77 112.529 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' B' ' 59' ' ' GLU . 17.6 pt20 -138.0 -49.23 0.56 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.047 -0.524 . . . . 1.99 110.411 167.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' B' ' 58' ' ' GLN . 33.7 tt0 164.25 113.57 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.677 0.791 . . . . 2.07 109.111 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m 58.65 52.74 6.56 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.433 -0.951 . . . . 1.37 108.433 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.135 0 CA-C-O 118.566 -1.13 . . . . 1.24 110.327 -170.415 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.634 ' HE2' ' CB ' ' A' ' 122' ' ' THR . 80.9 tttt . . . . . 0 N--CA 1.479 0.978 0 CA-C-O 120.693 0.282 . . . . 1.0600000000000001 110.566 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.1 m -92.72 95.61 9.66 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.213 -0.449 . . . . 0.71999999999999997 110.115 178.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.786 ' HA ' HG22 ' A' ' 122' ' ' THR . 28.9 mt-10 -87.77 113.27 23.28 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.532 0.682 . . . . 1.1399999999999999 110.595 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.711 HG21 ' HB ' ' A' ' 9' ' ' THR . 3.6 mm -81.37 -61.28 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.892 -1.049 . . . . 1.1399999999999999 110.46 -174.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 3' ' ' GLU . 39.9 m80 54.79 57.61 5.54 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.894 -0.594 . . . . 3.1400000000000001 110.577 -177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 117' ' ' VAL . . . -153.97 -156.61 7.73 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.361 -0.923 . . . . 1.6100000000000001 111.333 -178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.555 ' C ' HG22 ' A' ' 117' ' ' VAL . 7.6 m-20 -104.2 -17.79 14.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.185 0.492 . . . . 2.3599999999999999 111.577 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.569 ' HB2' ' HG2' ' A' ' 115' ' ' GLN . 20.0 p -160.74 157.52 27.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.163 0.506 . . . . 0.94999999999999996 111.174 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.711 ' HB ' HG21 ' A' ' 4' ' ' ILE . 11.8 t -153.05 165.33 35.93 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.069 -0.969 . . . . 0.80000000000000004 109.394 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 113' ' ' SER . 52.6 mtpt -139.84 134.56 31.89 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.356 0.598 . . . . 1.03 110.877 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.462 ' HB2' HD21 ' A' ' 123' ' ' LEU . . . -122.66 167.17 13.77 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.04 -0.982 . . . . 0.51000000000000001 110.07 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.6 m -108.13 112.38 24.88 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.679 -0.691 . . . . 0.5 109.245 176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 109' ' ' SER . 54.8 tp -84.28 154.6 22.86 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.169 -1.049 . . . . 1.23 108.169 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.698 ' HG3' ' HB3' ' A' ' 109' ' ' SER . 34.7 tt0 -150.13 141.37 23.17 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-O 121.359 0.6 . . . . 0.85999999999999999 109.539 174.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 75' ' ' LEU . 4.2 tm-20 -58.31 111.42 1.21 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.487 -1.233 . . . . 1.28 108.863 174.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' C ' ' HB2' ' A' ' 128' ' ' LEU . . . 107.64 -4.69 34.69 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 119.745 -1.217 . . . . 0.31 111.904 -171.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.702 ' HA ' ' HA ' ' A' ' 127' ' ' THR . 37.3 mt-30 -128.96 160.68 31.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.092 0.472 . . . . 1.22 110.728 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.476 ' CG ' ' HA ' ' A' ' 128' ' ' LEU . 1.7 mt-30 -123.59 161.66 24.53 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.425 -0.807 . . . . 1.2 109.128 175.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' O ' ' HA ' ' A' ' 72' ' ' THR . 11.4 mt -128.82 114.46 16.57 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.822 -0.436 . . . . 1.29 109.822 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.8 m -101.99 133.23 47.14 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.171 0.51 . . . . 0.47999999999999998 111.215 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 56.1 tp -122.57 115.09 21.56 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.798 -0.637 . . . . 1.24 111.125 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.46 HG23 HG23 ' A' ' 70' ' ' VAL . 2.6 m -93.98 99.7 11.98 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 109.023 -0.732 . . . . 0.37 109.023 170.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.678 ' CZ ' HD22 ' A' ' 28' ' ' LEU . 8.9 p90 -124.02 169.04 12.04 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.399 -0.593 . . . . 1.79 109.399 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 68' ' ' PRO . 37.5 mt -124.68 102.14 10.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 109.355 -0.609 . . . . 0.20000000000000001 109.355 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB3' ' HE2' ' A' ' 23' ' ' PHE . 16.9 t -134.88 170.56 15.68 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.517 -0.765 . . . . 1.1299999999999999 110.296 -175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.684 ' HB ' ' HG ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -127.0 -3.58 6.39 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.299 -0.864 . . . . 0.47999999999999998 110.69 174.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.631 ' HE2' ' HB2' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -170.96 71.32 0.05 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.661 -0.7 . . . . 1.3500000000000001 109.261 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.678 HD22 ' CZ ' ' A' ' 23' ' ' PHE . 0.5 OUTLIER -89.62 133.88 34.41 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.842 -0.617 . . . . 1.3500000000000001 110.97 -176.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -121.79 126.11 48.06 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.118 0.485 . . . . 2.0499999999999998 110.111 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.466 HG22 HD21 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -130.83 155.05 41.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.209 -0.596 . . . . 0.35999999999999999 110.89 -177.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.54 142.72 33.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.901 -1.045 . . . . 0.28999999999999998 109.835 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.657 ' HB ' ' HB3' ' A' ' 36' ' ' HIS . 62.9 t -106.7 133.75 50.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 115.328 -0.851 . . . . 0.70999999999999996 110.566 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.93 65.55 0.88 Allowed Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.717 -0.674 . . . . 1.0900000000000001 114.507 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.4 t -173.87 -71.53 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 106.687 -1.597 . . . . 3.1000000000000001 106.687 171.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 106' ' ' CYS . 0.5 OUTLIER -161.35 106.39 1.33 Allowed 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.727 -0.669 . . . . 1.9399999999999999 110.679 162.785 22.993 51.153 -158.064 105.727 2.041 105.739 -35.397 -50.026 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.756 ' HE1' HG21 ' A' ' 83' ' ' VAL . 15.2 t-160 -175.03 136.67 0.39 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.681 -0.859 . . . . 2.23 108.681 168.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -153.11 145.24 23.82 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 118.732 0.696 . . . . 1.25 109.951 171.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -151.97 161.2 43.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.113 0.483 . . . . 1.3400000000000001 111.231 -179.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.8 112.69 18.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.085 -0.961 . . . . 0.37 109.039 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -82.17 87.84 6.5 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.88 -0.785 . . . . 0.19 108.88 176.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.601 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 9.8 m120 -78.93 65.94 4.26 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.482 -0.781 . . . . 1.74 109.941 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.66 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 23.1 m-85 -56.26 -45.56 80.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.091 -0.958 . . . . 1.25 111.561 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.684 ' HG ' ' HB ' ' A' ' 26' ' ' THR . 60.7 mt -57.09 -53.61 56.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.078 -0.51 . . . . 1.4399999999999999 112.196 -177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -68.77 -19.87 64.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.898 0.856 . . . . 1.79 109.577 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.67 44.06 7.01 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.479 -1.237 . . . . 0.44 112.438 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.682 ' HB2' ' CG1' ' A' ' 59' ' ' VAL . 13.8 p90 -152.17 148.24 27.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.041 0.448 . . . . 1.28 110.561 176.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.684 ' HB3' HG13 ' A' ' 60' ' ' VAL . 2.0 tp -114.11 113.77 25.17 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.036 -0.529 . . . . 0.26000000000000001 110.571 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 58' ' ' ASP . 13.5 tttt -104.96 134.76 47.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.455 -0.339 . . . . 1.3200000000000001 110.776 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 37.6 p90 -146.63 141.27 26.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.854 -0.339 . . . . 1.24 111.892 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.612 HE21 ' HB2' ' A' ' 55' ' ' SER . 0.8 OUTLIER -121.87 162.15 21.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.037 0.446 . . . . 1.22 110.554 176.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.772 HG21 HG11 ' A' ' 101' ' ' VAL . 3.0 p -131.48 102.28 5.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.919 -0.582 . . . . 0.57999999999999996 110.839 174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.29 -172.42 22.72 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.714 -0.955 . . . . 1.8 110.714 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.8 m -74.24 -75.46 0.16 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.241 0.52 . . . . 3.6600000000000001 110.056 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -104.98 109.07 20.92 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.844 -0.798 . . . . 4.9100000000000001 108.844 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.612 ' HB2' HE21 ' A' ' 50' ' ' GLN . 15.0 m -151.98 158.76 43.54 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.211 -0.449 . . . . 2.1899999999999999 110.373 -176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.64 139.02 36.44 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.45 -0.796 . . . . 0.60999999999999999 110.273 177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.612 ' CE2' ' HG2' ' A' ' 50' ' ' GLN . 4.2 m-85 -90.56 128.61 36.63 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.745 -0.661 . . . . 1.24 110.005 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 3.5 t0 -77.54 154.24 32.61 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 108.242 -1.021 . . . . 1.75 108.242 172.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.682 ' CG1' ' HB2' ' A' ' 46' ' ' PHE . 39.8 t -112.43 133.12 59.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.257 0.551 . . . . 0.39000000000000001 111.068 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.789 ' HB ' HG21 ' B' ' 35' ' ' ILE . 0.4 OUTLIER -113.5 118.08 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 CA-C-N 115.412 -0.813 . . . . 1.3200000000000001 108.82 163.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.97 141.36 54.0 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.27 -0.877 . . . . 1.21 110.725 -175.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.626 HG11 ' HG3' ' A' ' 65' ' ' PRO . 3.6 t -114.72 139.57 40.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.291 -0.868 . . . . 1.1899999999999999 109.671 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 3.0 tp10 -86.93 50.37 2.0 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.52 -0.309 . . . . 2.3999999999999999 111.326 -170.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 59.86 79.99 0.28 Allowed Pre-proline 0 N--CA 1.469 0.501 0 CA-C-N 115.977 -0.556 . . . . 2.1299999999999999 112.031 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.66 ' HG2' ' HB3' ' A' ' 42' ' ' PHE . 3.0 Cg_exo -67.86 159.15 54.12 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.439 2.093 . . . . 0.35999999999999999 112.188 175.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.74 -8.43 17.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.26 -0.882 . . . . 0.39000000000000001 111.128 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.77 -67.22 0.55 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.827 -0.701 . . . . 0.20000000000000001 112.141 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.479 ' HA ' HG12 ' A' ' 24' ' ' ILE . 74.9 Cg_exo -48.66 120.5 5.32 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.111 2.54 . . . . 0.27000000000000002 112.503 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.694 ' HB1' HD21 ' A' ' 85' ' ' LEU . . . -147.1 139.65 24.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.241 0.543 . . . . 0.25 110.913 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 1.2 t -110.39 115.2 49.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.941 -0.763 . . . . 0.91000000000000003 108.941 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.564 HD21 HG13 ' A' ' 83' ' ' VAL . 2.7 tt -110.08 119.73 40.23 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.625 0.726 . . . . 1.1399999999999999 109.47 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.886 ' HB ' ' HB ' ' A' ' 84' ' ' VAL . 23.7 m -117.39 138.1 52.04 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.649 -1.159 . . . . 0.40000000000000002 110.36 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.656 HD13 HG11 ' A' ' 112' ' ' VAL . 3.9 mt -132.17 118.32 36.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 116.041 -0.527 . . . . 0.51000000000000001 111.079 -174.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -134.79 134.65 7.46 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.485 -0.864 . . . . 0.29999999999999999 112.294 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 16.1 tp -110.45 138.39 46.89 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.391 -0.596 . . . . 0.31 109.391 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' B' ' 49' ' ' THR . . . -131.79 23.72 4.16 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 119.621 -1.276 . . . . 0.48999999999999999 114.146 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.435 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 51.0 m-70 -159.69 -63.35 0.07 Allowed 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 122.138 0.97 . . . . 1.9299999999999999 109.544 172.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 106' ' ' CYS . 0.0 OUTLIER 176.58 -50.31 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.424 -1.716 . . . . 2.2400000000000002 107.842 -172.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 78' ' ' LYS . . . -109.93 -22.89 6.38 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.406 -0.816 . . . . 0.38 111.54 176.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -74.21 97.8 3.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.924 -0.31 . . . . 1.6499999999999999 110.446 -177.069 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.498 ' HG ' ' HB ' ' A' ' 101' ' ' VAL . 4.2 pp -115.59 151.22 35.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 1.3999999999999999 111.252 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.609 ' HB2' ' C ' ' B' ' 50' ' ' GLY . . . -125.22 132.45 52.98 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.677 -0.692 . . . . 0.34000000000000002 109.564 177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.756 HG21 ' HE1' ' A' ' 36' ' ' HIS . 38.6 t -121.01 117.87 54.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.99 0.424 . . . . 1.3600000000000001 110.829 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.891 HG13 ' HB ' ' B' ' 44' ' ' ILE . 86.4 t -101.38 126.74 55.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.934 -1.03 . . . . 1.25 109.729 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.694 HD21 ' HB1' ' A' ' 69' ' ' ALA . 3.5 tm? -122.55 123.45 41.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.349 -0.611 . . . . 1.2 109.349 173.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 72.3 m-20 -118.62 110.59 17.5 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.574 -0.899 . . . . 1.8899999999999999 108.574 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.527 ' HB2' ' HB3' ' A' ' 65' ' ' PRO . 41.8 p90 -118.45 138.3 52.57 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.635 0.731 . . . . 0.23999999999999999 111.409 -173.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.882 ' HA ' HD12 ' A' ' 94' ' ' LEU . 20.4 m -73.11 131.6 42.26 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.942 -0.762 . . . . 0.33000000000000002 108.942 171.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 46.2 mtp180 -95.2 145.43 25.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.104 0.478 . . . . 2.2000000000000002 111.799 -174.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 mt -71.95 -11.88 60.99 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.393 -0.821 . . . . 0.56000000000000005 111.045 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -92.73 40.18 1.05 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.8 -0.636 . . . . 1.5700000000000001 111.129 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.03 28.44 17.23 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.505 0.503 . . . . 1.1000000000000001 111.911 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.691 ' HB1' ' HG3' ' B' ' 40' ' ' GLN . . . -150.4 -176.02 5.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.992 0.425 . . . . 0.44 110.607 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.882 HD12 ' HA ' ' A' ' 88' ' ' THR . 5.9 tp -116.75 158.45 23.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.183 -1.043 . . . . 1.26 108.183 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.405 ' N ' ' HG ' ' A' ' 94' ' ' LEU . . . -145.88 131.21 4.04 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 110.034 -1.226 . . . . 0.28999999999999998 110.034 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.693 ' CB ' ' HA ' ' B' ' 43' ' ' ARG . 18.0 m -123.4 146.65 47.82 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.2 -0.6 . . . . 1.3200000000000001 110.21 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' B' ' 37' ' ' ARG . . . -147.31 158.93 44.15 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 122.327 0.251 . . . . 0.59999999999999998 110.471 -173.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.8 ' CB ' HG21 ' B' ' 44' ' ' ILE . . . -154.76 170.0 22.62 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.255 0.55 . . . . 0.17000000000000001 112.29 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.539 ' HB3' HG12 ' B' ' 35' ' ' ILE . 16.9 p90 -152.9 156.92 39.86 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.15 -0.932 . . . . 0.38 108.64 172.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.719 ' CG1' HG22 ' B' ' 52' ' ' VAL . 0.6 OUTLIER -133.0 144.05 37.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.881 -0.785 . . . . 1.22 108.881 -177.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.8 ' O ' ' HA ' ' A' ' 80' ' ' ARG . 91.5 t -122.33 106.52 17.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.555 -0.748 . . . . 1.3600000000000001 109.467 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.671 ' HA ' ' HG2' ' A' ' 80' ' ' ARG . 15.8 mm-40 -62.47 -34.48 76.91 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.343 -1.299 . . . . 1.4299999999999999 112.031 -173.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -144.99 92.8 2.31 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.398 0.618 . . . . 1.0 110.662 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 23.1 t -75.62 -13.93 60.35 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.081 -0.963 . . . . 1.3600000000000001 109.54 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.74 28.58 38.07 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.591 -0.731 . . . . 0.77000000000000002 113.176 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 78' ' ' LYS . 31.0 m -109.08 175.01 5.61 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.595 -0.52 . . . . 0.62 109.595 -173.721 -50.026 -35.397 -158.064 105.739 2.041 105.727 51.153 22.993 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.6 p -117.59 156.67 27.71 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.057 -0.349 . . . . 1.6899999999999999 110.057 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 p -46.74 140.76 4.33 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.526 0.565 . . . . 1.1399999999999999 112.526 -176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.698 ' HB3' ' HG3' ' A' ' 14' ' ' GLU . 80.1 p 63.83 86.17 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.192 0.997 . . . . 0.51000000000000001 112.611 171.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.495 ' HG3' ' CG1' ' A' ' 32' ' ' VAL . 1.5 pm0 -119.43 155.79 31.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.456 -1.247 . . . . 2.6400000000000001 110.148 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -89.1 116.07 27.1 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 120.886 0.374 . . . . 0.75 111.125 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.656 HG11 HD13 ' A' ' 73' ' ' ILE . 93.0 t -96.05 123.96 48.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.064 0.459 . . . . 1.1499999999999999 111.189 -176.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.454 ' HA ' ' HG2' ' A' ' 10' ' ' LYS . 32.8 t -104.18 115.27 30.11 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.879 -0.6 . . . . 0.70999999999999996 110.582 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.442 ' HA ' ' HB ' ' A' ' 30' ' ' VAL . 20.8 m-85 -99.88 115.75 30.33 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.419 -0.585 . . . . 3.6499999999999999 109.419 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.569 ' HG2' ' HB2' ' A' ' 8' ' ' SER . 21.1 mt-30 -130.82 143.48 50.76 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.296 0.57 . . . . 1.3600000000000001 111.919 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.79 19.75 36.19 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.751 -0.94 . . . . 0.32000000000000001 110.751 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.617 ' HB ' ' HB2' ' A' ' 121' ' ' ALA . 35.6 m -65.2 -18.11 23.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.906 0.384 . . . . 0.85999999999999999 111.211 -175.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.85 -89.94 1.27 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.718 -0.674 . . . . 0.95999999999999996 112.818 173.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.9 t -161.16 156.58 24.54 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 108.582 -0.896 . . . . 1.3600000000000001 108.582 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.12 5.36 70.85 Favored Glycine 0 CA--C 1.506 -0.493 0 C-N-CA 120.517 -0.849 . . . . 0.5 112.442 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.617 ' HB2' ' HB ' ' A' ' 117' ' ' VAL . . . -65.91 133.78 51.61 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 120.669 0.271 . . . . 0.40000000000000002 111.248 -176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.786 HG22 ' HA ' ' A' ' 3' ' ' GLU . 41.4 p -147.01 132.78 18.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.808 -0.633 . . . . 0.48999999999999999 109.775 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 11' ' ' ALA . 7.7 tp -106.37 148.65 27.82 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.193 0.52 . . . . 1.0900000000000001 111.118 -176.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.511 HG22 ' HG3' ' A' ' 1' ' ' LYS . 97.9 t -140.59 125.74 19.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.366 -0.834 . . . . 0.55000000000000004 109.459 173.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.485 HG23 HD23 ' A' ' 19' ' ' LEU . 13.2 p -93.44 131.85 39.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.505 0.669 . . . . 1.22 110.434 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.449 ' OG1' ' HB2' ' A' ' 18' ' ' GLN . 0.7 OUTLIER -124.29 179.59 4.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.491 -0.777 . . . . 0.58999999999999997 110.755 -178.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.702 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 0.6 OUTLIER -103.54 156.36 17.83 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.711 -0.477 . . . . 0.46999999999999997 109.711 170.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.539 ' HB2' ' C ' ' A' ' 16' ' ' GLY . 11.7 tp -55.94 159.27 3.31 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.067 0.855 . . . . 1.4399999999999999 111.279 -171.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' B' ' 46' ' ' LEU . . . -75.15 -128.68 0.21 Allowed Glycine 0 CA--C 1.533 1.162 0 N-CA-C 114.53 0.572 . . . . 1.74 114.53 -169.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.765 ' H ' ' HA ' ' B' ' 47' ' ' ASP . 34.2 tt0 -163.82 141.48 7.27 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.303 0.483 . . . . 3.6000000000000001 112.303 178.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 48.6 m 82.51 97.7 0.03 OUTLIER Pre-proline 0 N--CA 1.48 1.051 0 C-N-CA 124.241 1.016 . . . . 2.4500000000000002 113.27 172.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.83 ' HB3' HG21 ' B' ' 49' ' ' THR . 59.2 Cg_endo -73.3 144.38 36.81 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.582 2.855 . . . . 1.4199999999999999 113.749 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.421 HG22 ' HB3' ' B' ' 18' ' ' PRO . 2.3 m -175.29 114.41 0.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.439 0.695 . . . . 1.26 111.001 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.567 ' O ' ' HB ' ' B' ' 10' ' ' THR . . . -173.02 171.86 4.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.72 -0.845 . . . . 0.53000000000000003 108.72 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.848 ' HB ' ' H ' ' B' ' 13' ' ' ALA . 7.9 p -99.21 -28.25 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 113.419 0.896 . . . . 1.98 113.419 -170.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.655 ' H ' ' HG3' ' A' ' 102' ' ' GLU . 35.6 t . . . . . 0 C--O 1.25 1.112 0 O-C-N 123.753 0.658 . . . . 1.6699999999999999 109.302 -167.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 110.252 -0.277 . . . . 7.2599999999999998 110.252 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 1.6 p -77.68 82.9 4.07 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.289 0.566 . . . . 4.6900000000000004 112.354 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -131.1 -63.61 0.85 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.309 -0.86 . . . . 3.7000000000000002 109.553 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 134' ' ' ALA . 2.6 p -87.5 146.83 40.42 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.029 -0.987 . . . . 1.4199999999999999 112.384 -174.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.535 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 72.6 Cg_endo -78.24 156.27 29.46 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.158 2.572 . . . . 0.69999999999999996 110.999 172.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . 0.531 ' HB3' ' HB3' ' B' ' 15' ' ' SER . . . -63.94 110.85 2.25 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.035 -0.728 . . . . 0.65000000000000002 109.035 177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.848 ' H ' ' HB ' ' A' ' 135' ' ' VAL . . . -46.27 -78.31 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 O-C-N 123.6 0.563 . . . . 0.46000000000000002 112.426 -167.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' CYS . . . . . 0.486 ' HB2' ' HG3' ' B' ' 29' ' ' GLU . 0.5 OUTLIER -65.79 -25.55 67.29 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.219 -0.301 . . . . 0.59999999999999998 111.618 -175.087 -141.968 43.565 -175.268 103.422 2.034 103.815 -98.847 169.908 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' B' ' 12' ' ' ALA . 39.8 t -72.94 -29.84 63.4 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.884 0.327 . . . . 1.5 111.884 -178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' B' ' 17' ' ' ASN . 43.8 p -88.55 -10.62 48.23 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.943 0.401 . . . . 0.56999999999999995 111.648 -176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' B' ' 16' ' ' SER . 12.7 m120 79.12 71.28 0.17 Allowed Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 115.165 -0.925 . . . . 1.54 111.007 174.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.445 ' HB2' ' CE2' ' B' ' 34' ' ' TYR . 76.1 Cg_endo -91.19 -61.24 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.251 2.634 . . . . 0.33000000000000002 111.527 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.75 31.52 0.69 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.815 0.817 . . . . 1.04 108.98 173.956 -22.012 -91.664 -52.767 103.516 2.026 103.496 -49.262 -61.909 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' B' ' 21' ' ' PRO . . . -127.65 41.51 1.58 Allowed Glycine 0 C--N 1.308 -1.013 0 CA-C-N 114.496 -1.229 . . . . 0.64000000000000001 114.031 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' B' ' 24' ' ' ALA . 30.3 Cg_endo -68.8 -172.25 0.46 Allowed 'Trans proline' 0 C--N 1.358 1.065 0 CA-C-N 119.706 1.753 . . . . 1.1699999999999999 111.009 169.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -75.61 5.09 6.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.376 0.608 . . . . 2.4399999999999999 109.809 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ALA . . . . . 0.49 ' HB1' ' CD1' ' B' ' 42' ' ' TYR . . . -115.03 -50.35 2.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.441 -0.799 . . . . 0.40000000000000002 112.243 -175.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' B' ' 54' ' ' CYS . . . -63.22 166.17 6.49 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.654 0.983 . . . . 0.28999999999999998 113.654 -167.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . -110.31 -42.3 1.18 Allowed Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 114.122 -1.399 . . . . 0.39000000000000001 113.243 -171.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.634 ' HB ' ' HB2' ' B' ' 37' ' ' ARG . 0.2 OUTLIER -144.63 150.43 37.4 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 117.253 0.526 . . . . 0.26000000000000001 112.189 -174.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 14.7 t -133.85 136.95 44.74 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.648 -0.705 . . . . 0.35999999999999999 110.03 178.708 169.908 -98.847 -175.268 103.815 2.034 103.422 43.565 -141.968 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . 0.534 ' HD3' ' CD1' ' B' ' 35' ' ' ILE . 39.6 tttm -146.3 115.22 6.92 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 122.12 0.168 . . . . 1.3899999999999999 110.995 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . 0.748 ' HG2' ' HB3' ' B' ' 13' ' ' ALA . 11.5 mt-10 -76.44 141.07 41.49 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 121.767 -0.583 . . . . 1.8300000000000001 110.547 175.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.8 p -115.7 -166.48 1.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.835 -0.62 . . . . 0.5 110.738 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -91.4 -5.71 54.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.53 -0.544 . . . . 1.6699999999999999 109.53 175.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' SER . . . . . 0.694 ' HB3' HG13 ' A' ' 101' ' ' VAL . 12.9 m -133.62 21.03 3.91 Favored 'General case' 0 C--O 1.215 -0.747 0 CA-C-N 116.006 -0.543 . . . . 1.5900000000000001 111.584 -174.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.97 -119.03 1.75 Allowed Glycine 0 N--CA 1.429 -1.792 0 N-CA-C 108.702 -1.759 . . . . 0.51000000000000001 108.702 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' TYR . . . . . 0.667 ' OH ' ' HB3' ' B' ' 51' ' ' ASN . 0.5 OUTLIER -155.08 168.09 28.19 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.42 0.629 . . . . 1.23 111.203 178.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.789 HG21 ' HB ' ' A' ' 60' ' ' VAL . 44.1 mt -121.15 140.53 45.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.494 -1.23 . . . . 0.25 108.83 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . 0.635 ' SG ' HG23 ' B' ' 52' ' ' VAL . 72.8 m -122.21 151.89 40.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.164 0.507 . . . . 0.94999999999999996 110.182 179.042 -61.909 -49.262 -52.767 103.496 2.026 103.516 -91.664 -22.012 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ARG . . . . . 0.636 ' HD2' HG23 ' A' ' 60' ' ' VAL . 4.8 mtp85 -142.71 137.56 29.94 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.132 -0.692 . . . . 1.73 109.132 174.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' CYS . . . . . 0.784 ' SG ' HG12 ' B' ' 44' ' ' ILE . 83.2 m -97.44 170.59 8.95 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.246 1.022 . . . . 0.26000000000000001 112.908 -176.818 -59.297 -35.081 -96.036 103.171 2.024 102.627 -84.985 -66.456 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASN . . . . . 0.626 ' HB3' ' CD2' ' B' ' 42' ' ' TYR . 23.0 t-20 -91.64 177.38 6.23 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.133 -1.848 . . . . 0.65000000000000002 108.619 175.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLN . . . . . 0.691 ' HG3' ' HB1' ' A' ' 93' ' ' ALA . 50.4 tt0 -47.91 -52.2 20.33 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.772 0.656 . . . . 1.53 112.772 -176.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLY . . . . . . . . . . . . . . . -87.52 17.31 44.88 Favored Glycine 0 CA--C 1.506 -0.475 0 C-N-CA 120.857 -0.687 . . . . 0.45000000000000001 114.148 -172.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.626 ' CD2' ' HB3' ' B' ' 39' ' ' ASN . 24.9 m-85 -134.59 156.17 49.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 118.504 1.152 . . . . 0.40000000000000002 112.021 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.693 ' HA ' ' CB ' ' A' ' 96' ' ' SER . 40.5 mtt180 -128.99 161.89 28.87 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 113.948 -1.478 . . . . 1.0900000000000001 108.768 173.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.891 ' HB ' HG13 ' A' ' 84' ' ' VAL . 2.5 mm -85.37 124.95 40.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.069 -0.514 . . . . 0.23000000000000001 111.601 -174.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -104.4 114.19 28.26 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.986 -0.746 . . . . 0.92000000000000004 108.986 175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.667 ' O ' ' HA3' ' A' ' 129' ' ' GLY . 0.5 OUTLIER -82.29 148.09 28.53 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.718 -0.674 . . . . 1.0 109.863 -179.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . 0.765 ' HA ' ' H ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -96.19 -175.7 3.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 122.215 1.007 . . . . 2.5699999999999998 112.589 -171.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . 0.511 ' HA2' ' HG ' ' A' ' 128' ' ' LEU . . . -89.23 23.11 19.84 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 113.985 -1.462 . . . . 0.83999999999999997 111.657 -170.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.83 HG21 ' HB3' ' A' ' 132' ' ' PRO . 23.3 p -137.6 -29.25 0.87 Allowed 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 115.329 -0.435 . . . . 0.96999999999999997 110.204 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . 0.609 ' C ' ' HB2' ' A' ' 82' ' ' ALA . . . 125.87 34.99 0.61 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.94 -0.648 . . . . 0.53000000000000003 111.857 176.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.667 ' HB3' ' OH ' ' B' ' 34' ' ' TYR . 12.5 m120 -121.3 179.51 4.39 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.041 -1.096 . . . . 2.3500000000000001 108.041 177.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.719 HG22 ' CG1' ' A' ' 100' ' ' VAL . 8.7 m -148.43 149.86 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.208 0.818 . . . . 1.2 113.208 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 8.7 t -159.07 165.73 33.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.432 -0.804 . . . . 0.31 109.962 173.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' CYS . . . . . 0.705 ' HB2' ' HB2' ' B' ' 24' ' ' ALA . 92.3 m -99.36 138.01 37.06 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.304 1.224 . . . . 0.75 114.304 -169.395 -66.456 -84.985 -96.036 102.627 2.024 103.171 -35.081 -59.297 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . . . . . . . . . 6.0 pt -142.48 169.68 12.64 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.523 0 CA-C-N 114.314 -1.312 . . . . 0.47999999999999998 109.859 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' VAL . . . . . 0.403 HG13 ' H ' ' B' ' 56' ' ' VAL . 1.1 m -43.3 134.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-O 122.557 1.17 . . . . 1.3 111.804 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.514 ' HD2' HD22 ' A' ' 94' ' ' LEU . 18.6 ptt180 -62.83 116.56 5.36 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 113.389 -1.732 . . . . 3.77 112.529 -176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' B' ' 59' ' ' GLU . 17.6 pt20 -138.0 -49.23 0.56 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.047 -0.524 . . . . 1.99 110.411 167.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' B' ' 58' ' ' GLN . 33.7 tt0 164.25 113.57 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.677 0.791 . . . . 2.0699999999999998 109.111 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m 58.65 52.74 6.56 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.433 -0.951 . . . . 1.3700000000000001 108.433 -174.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.135 0 CA-C-O 118.566 -1.13 . . . . 1.24 110.327 -170.415 . . . . . . . . 0 0 . 1 stop_ save_